Côte d'Ivoire vs Guinea-Bissau: Share of the population living with HIV
Côte d'Ivoire
1.7%
in 2024
Guinea-Bissau
2.2%
in 2024
Côte d'Ivoire rank
19th
Guinea-Bissau rank
17th
Share of the population living with HIV over time
- Côte d'Ivoire
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 2.2% against 1.7% in Côte d'Ivoire, a difference of 0.5%.
That makes Guinea-Bissau's figure about 1.3 times Côte d'Ivoire's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 19th and Guinea-Bissau ranks 17th of 150 countries.
Across the 4 decades both report, Côte d'Ivoire averaged higher in 2 and Guinea-Bissau in 2.
Head to head by decade
| Decade | Côte d'Ivoire | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.8% | 1.4% | 5.4% | Côte d'Ivoire |
| 2000s | 5.2% | 4.3% | 0.9% | Côte d'Ivoire |
| 2010s | 2.8% | 3.4% | 0.5% | Guinea-Bissau |
| 2020s | 1.9% | 2.4% | 0.5% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv, Côte d'Ivoire or Guinea-Bissau?
- Guinea-Bissau, at 2.2% against 1.7% in Côte d'Ivoire as of 2024.
- What is the difference in share of the population living with hiv between Côte d'Ivoire and Guinea-Bissau?
- 0.5%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Côte d'Ivoire and Guinea-Bissau?
- 35 years are reported by both, from 1990 to 2024.
- How do Côte d'Ivoire and Guinea-Bissau rank globally for share of the population living with hiv?
- Côte d'Ivoire ranks 19th and Guinea-Bissau ranks 17th of 150 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 15-49 who test positive for HIV at a given time. This is the central estimate.